Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Pediatrix Medical (MD) Receivables Refunds (2020 - 2025)

Pediatrix Medical (MD) has disclosed Receivables Refunds for 7 consecutive years, with $12.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables Refunds changed 0.21% to $12.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.6 million, a 0.21% change, with the full-year FY2025 number at $12.6 million, changed 0.21% from a year prior.
  • Receivables Refunds was $12.6 million for Q4 2025 at Pediatrix Medical, up from $3.8 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $29.1 million in Q2 2021 to a low of $1.2 million in Q3 2024.
  • A 5-year average of $12.3 million and a median of $11.4 million in 2024 define the central range for Receivables Refunds.
  • Peak YoY movement for Receivables Refunds: tumbled 54.9% in 2021, then surged 218.45% in 2025.
  • Pediatrix Medical's Receivables Refunds stood at $14.2 million in 2021, then tumbled by 31.72% to $9.7 million in 2022, then decreased by 22.24% to $7.6 million in 2023, then soared by 66.74% to $12.6 million in 2024, then increased by 0.21% to $12.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Receivables Refunds are $12.6 million (Q4 2025), $3.8 million (Q3 2025), and $7.6 million (Q2 2025).